Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pediatric Rheumatology
Published in: Pediatric Rheumatology 1/2013

Open Access 01-11-2013 | Meeting abstract

P01-031 – Anakinra for colchicine resistant FMF

Authors: I Ben-Zvi, OL Kukuy, M Lidar, O Feld, O Perski, S Kivity, P Langevitz, B Pistrom, A Livneh

Published in: Pediatric Rheumatology | Special Issue 1/2013

Login to get access

Excerpt

About 10-20% of Familial Mediterranean Fever (FMF) patients do not achieve complete remission, due to colchicine resistance or sensitivity. Disease control in these patients is still an unmet challenge. Case reports and a small case control study, suggest a role for interleukin 1 beta blockage, particularly anakinra, in the management of this limitation of colchicines. …
Metadata
Title
P01-031 – Anakinra for colchicine resistant FMF
Authors
I Ben-Zvi
OL Kukuy
M Lidar
O Feld
O Perski
S Kivity
P Langevitz
B Pistrom
A Livneh
Publication date
01-11-2013
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue Special Issue 1/2013
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/1546-0096-11-S1-A35

Other articles of this Special Issue 1/2013

Pediatric Rheumatology 1/2013 Go to the issue

Meeting abstract

P01-015 – Effect of Cochicine on cholesterol in FMF and BS

Meeting abstract

P01-033 – Co-occurance of Crohn’s disease and FMF

Meeting abstract

P01-019 – Anti-CCP antibodies are not associated with FMF

Meeting abstract

OR6-006 – IL36RN alleles in skin auto-inflammation

Meeting abstract

P01-034 – Cancer in FMF: a population based study Israel

Meeting abstract

OR7-005 – Canakinumab in childhood colchicine resistant FMF